Search results for "Metas"

showing 10 items of 1693 documents

Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers

2015

Background: 18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) accumulations are commonly seen in the neck-related muscles of the surgical and non-surgical sides after surgery with neck dissection (ND) for oral cancers, which leads to radiologists having difficulty in diagnosing the lesions. To examine the alterations in 18 F-FDG accumulation in neck-related muscles of patients after ND for oral cancer. Material and Methods: 18 F-FDG accumulations on positron emission tomography (PET)-computed tomography (CT) in neck-related muscles were retrospectively analyzed after surgical dissection of cervical lymph nodes in oral cancers. Results: According to the extent of ND of cervical lymph nodes, the rate…

medicine.medical_specialtymedicine.medical_treatmentOdontología030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18medicineHumansGeneral DentistryMouth neoplasmOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryResearchCancerNeck dissection:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludNeck musclesSurgerycarbohydrates (lipids)Dissectionmedicine.anatomical_structureOtorhinolaryngologyCervical lymph nodesPositron emission tomographyLymphatic MetastasisPositron-Emission Tomography030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASNeck DissectionOral CancersMouth NeoplasmsSurgeryRadiologyRadiopharmaceuticalsTomography X-Ray ComputedbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissec…

2009

Background: This prospective multicenter study assessed and compared the impact of different surgical procedures on quality of life (QoL) in breast cancer patients. Patients and methods: The EORTC QLQ-C30 and the EORTC QLQ-BR-23 questionnaires were used to assess global health status (GHS), arm (BRAS) and breast (BRBS) symptom scales, before surgery, just after surgery and 6 and 12 months later. The Kruskal–Wallis test with the Bonferroni correction was used to compare scores. A mixed model analysis of variance for repeated measurements was then applied to assess the longitudinal effect of surgical modalities on QoL. Results: Before surgery, GHS (P = 0.7807) and BRAS (P = 0.7688) QoL scores…

medicine.medical_specialtymedicine.medical_treatmentSentinel lymph nodeBreast NeoplasmsCohort StudiesBreast cancerQuality of lifemedicineHumansProspective Studiesbusiness.industrySentinel Lymph Node BiopsyAxillary Lymph Node DissectionHematologySentinel nodeMiddle Agedmedicine.diseasehumanitiesSurgeryOncologyLymphatic MetastasisQuality of LifeLymph Node ExcisionLymphadenectomyFemaleBreast diseaseLymph NodesbusinessCohort studyAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Predictive Score of Nodal Involvement in Endometrial Cancer Patients: A Large Multicentre Series

2021

Background: Sentinel lymph node (SLN) biopsy is considered the standard of care in early-stage endometrial cancer (EC). For SLN failure, a side-specific lymphadenectomy is recommended. Nevertheless, most hemipelvises show no nodal involvement. The authors previously published a predictive score of lymphovascular involvement in EC. In case of a negative score (value 3–4), the risk of nodal metastases was extremely low. This multicenter study aimed to analyze a predictive score of nodal involvement in EC patients. Methods: The study enrolled patients with EC who had received comprehensive surgical staging with nodal assessment. A preoperative predictive score of nodal involvement was calculat…

medicine.medical_specialtymedicine.medical_treatmentSentinel lymph nodeLogistic regressionBiopsyHumansMedicineEndometrial NeoplasmNeoplasm Stagingmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyEndometrial cancerArea under the curveLymph NodeLymphatic MetastasiOdds ratiomedicine.diseaseConfidence intervalEndometrial NeoplasmsOncologyLymphatic MetastasisLymph Node ExcisionSurgeryLymphadenectomyFemaleLymph NodesRadiologySentinel Lymph NodebusinessHuman
researchProduct

Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of c…

2021

Abstract Introduction Sentinel lymph node biopsy (SLNB) after neoadjuvant therapy (NAT) in node-positive (N+) breast cancer patients at diagnosis remains a controversial issue, with no consensus on implementation or safety. Objectives We sought to assess the accuracy of SLNB after NAT in biopsy-proven N+ cases at diagnosis and the efficacy and accuracy of wire localization of the clipped node to improve results. Material and methods A cross-sectional diagnostic technique validation study in N+ patients following NAT was performed. The biopsy-proven affected lymph node was clipped at diagnosis. SLNB and axillary lymph node dissection (ALND) were performed in cases of clinical-radiological ly…

medicine.medical_specialtymedicine.medical_treatmentWire localizationSentinel lymph nodeBreast Neoplasms03 medical and health sciences0302 clinical medicineBreast cancerBiopsymedicineHumans030212 general & internal medicineLymph nodeNeoadjuvant therapyNeoplasm Stagingmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyAxillary Lymph Node DissectionMiddle Agedmedicine.diseaseSurgical InstrumentsNeoadjuvant Therapymedicine.anatomical_structureCross-Sectional Studies030220 oncology & carcinogenesisLymphatic MetastasisAxillaLymph Node ExcisionSurgeryNode (circuits)FemaleRadiologyLymph NodesSentinel Lymph NodebusinessThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
researchProduct

Pancoast's syndrome caused by lymph node metastasis from breast cancer.

2018

Pancoast’s syndrome may be the result of neoplastic, inflammatory or infectious disease. We report an unusual case of Pancoast’s syndrome in a patient with metastatic breast cancer. A 54-year-old woman, affected by metastatic breast cancer, presented for severe shoulder pain, paraesthesia and numbness in the right arm. Despite further multiple lines of systemic chemotherapy, she developed a progressive enlargement of retropectoral, supraclavicular and infraclavicular lymph node metastases, which involved brachial plexus, apex of lung and anterior mediastinum. Physical examination revealed severe weakness of proximal muscles of the right arm. Neuropathic pain was managed with pharmacological…

medicine.medical_specialtypain (palliative care)Settore MED/06 - Oncologia MedicaPhysical examinationBreast Neoplasmspain (neurology)03 medical and health sciencesbreast cancer0302 clinical medicineBreast cancerFatal OutcomeShoulder PainmedicineHumansPain ManagementBrachial PlexusInfraclavicular Lymph NodeZiconotideLungUnusual Presentation of More Common Disease/Injurymedicine.diagnostic_testperipheral nerve diseasebusiness.industryPancoast SyndromeGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancermedicine.anatomical_structure030220 oncology & carcinogenesisLymphatic MetastasisNeuropathic painNeuralgiaSettore MED/26 - NeurologiaFemaleRadiologyLymph NodesbusinessBrachial plexus030217 neurology & neurosurgerymedicine.drugBMJ case reports
researchProduct

Laparoscopy versus open adrenalectomy in patients with solid tumor metastases: results of a multicenter European study

2020

Background: The outcome of adrenalectomy carried out by laparoscopy or open surgery for solid tumor metastases was assessed. Methods: A total of 317 patients with histologically confirmed adrenal metastatic disease collected from 30 centres in Europe underwent adrenalectomy by laparoscopy (n=146) or open laparotomy (n=171). Differences between laparoscopic and open adrenalectomy were assessed by a single Cox analysis for both procedures. Results: The median overall survival was 24.0 [95% confidence interval (CI): 21.4-26.6] months for open adrenalectomy and 45.0 (95% CI: 22.6-67.4) for laparoscopic adrenalectomy (P=0.008). Survival rates were 68%, 49%, 35% and 29% at 1, 2, 3 and 5 years for…

medicine.medical_specialtyretrospective studymedicine.medical_treatmentUrologysurvivalMetastasis03 medical and health sciences0302 clinical medicineMetàstasiLaparotomymedicineLaparoscopyTumorsChemotherapymedicine.diagnostic_testbusiness.industryAdrenalectomyHazard ratioopen adrenalectomyAdrenalectomyRetrospective cohort studymedicine.diseasePrimary tumorConfidence interval3. Good healthLaparoscòpiaAdrenalectomy; open adrenalectomy; laparoscopic adrenalectomy; survival; retrospective study030220 oncology & carcinogenesisOriginal ArticleLaparoscopy030211 gastroenterology & hepatologySurgerybusinesslaparoscopic adrenalectomyGland Surgery
researchProduct

Predictors of Central Compartment Involvement in Patients with Positive Lateral Cervical Lymph Nodes According to Clinical and/or Ultrasound Evaluati…

2021

Lymph node neck metastases are frequent in papillary thyroid carcinoma (PTC). Current guidelines state, on a weak level of evidence, that level VI dissection is mandatory in the presence of latero-cervical metastases. The aim of our study is to evaluate predictive factors for the absence of level VI involvement despite the presence of metastases to the lateral cervical stations in PTC. Eighty-eight patients operated for PTC with level II–V metastases were retrospectively enrolled in the study. Demographics, thyroid function, autoimmunity, nodule size and site, cancer variant, multifocality, Bethesda and EU-TIRADS, number of central and lateral lymph nodes removed, number of positive lymph n…

medicine.medical_specialtyskip metastasisendocrine system diseasesmedicine.medical_treatment030230 surgeryArticle03 medical and health sciences0302 clinical medicinecentral compartmentmedicinelateralcervical lymph nodesLymph nodeUnivariate analysisbusiness.industryEU-TIRADSBethesdaRCancerNeck dissectionGeneral Medicinemedicine.diseaseCentral lymphDissectionmedicine.anatomical_structurelateral neck dissection030220 oncology & carcinogenesiscentral neck dissectionpapillary thyroid carcinomaMedicineRadiologyLymphThyroid functionbusinessJournal of clinical medicine
researchProduct

Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients

2005

Abstract Purpose The aim of this study is to describe the University of Florence experience in evaluating clinical, pathologic and treatment factors as they are related to the outcome and loco-regional recurrence in patients with tubular breast carcinoma. Material and methods Three hundred and seven patients (median age 56.4 years, range 26–91 years) with histological verified tubular carcinoma of the breast were consecutively treated at University of Florence from 1976 to 2001. All patients were followed for a median of 8.4 years (range 3 months to 20 years). Thirty-seven women underwent mastectomy and 270 underwent breast conserving surgery. Positive axillary nodes were found in 15% of pa…

medicine.medical_treatmentDiseaseSegmentalMastectomy SegmentalBreast cancerDuctalBreast-conserving surgery80 and overBreastAdjuvantMastectomyAged 80 and overCarcinoma Ductal BreastTubular carcinomaGeneral MedicineMiddle AgedCombined Modality TherapyTreatment OutcomeBreast cancer; Radiotherapy; Tubular carcinoma; Adenocarcinoma; Adult; Aged; Aged 80 and over; Antineoplastic Agents Hormonal; Axilla; Breast Neoplasms; Carcinoma Ductal Breast; Chemotherapy Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Mastectomy; Mastectomy Segmental; Middle Aged; Neoplasm Recurrence Local; Proportional Hazards Models; Radiotherapy Adjuvant; Survival Analysis; Tamoxifen; Treatment Outcome; Oncology; SurgeryLocalOncologyChemotherapy AdjuvantLymphatic MetastasisFemaleMastectomymedicine.drugAdultmedicine.medical_specialtyAntineoplastic Agents HormonalAntineoplastic AgentsBreast NeoplasmsAdenocarcinomaBreast cancermedicineChemotherapyHumansAgedProportional Hazards ModelsChemotherapyRadiotherapyHormonalbusiness.industryCarcinomamedicine.diseaseSurvival AnalysisSurgeryRadiation therapyTamoxifenNeoplasm RecurrenceAxillaRadiotherapy AdjuvantSurgeryTubular carcinomaNeoplasm Recurrence LocalbusinessTamoxifen
researchProduct

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

2020

The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified because of its key role in the regulation of glycogen synthesis. However, it is now well-established that GSK-3 performs critical functions in many cellular processes, such as apoptosis, tumor growth, cell invasion, and metastasis. Aberrant GSK-3 activity has been associated with many human diseases, including cancer, highlighting its potential therapeutic relevance as a target for anticancer therapy. Recently, newly emerging data have demonstrated the pivotal role of GSK-3 in the anticancer immune response. In the last few years, many GSK-3 inhibitors have been developed, and some are currently being te…

medicine.medical_treatmentT cellsReviewmacromolecular substancesNK cellsMetastasisGlycogen Synthase Kinase 3MiceImmune systemCancer immunotherapyGSK-3NeoplasmsPD-1medicineAnimalsHumanscancerGlycogen synthaselcsh:QH301-705.5GSK-3biologyKinasebusiness.industryCancerGeneral MedicineImmunotherapymedicine.diseasesmall molecule inhibitorsDisease Models Animalglycogen synthase kinase-3 (GSK-3)lcsh:Biology (General)Cancer researchbiology.proteinCTLA-4immunotherapybusiness
researchProduct

Bakteriofāga izcelsmes dsRNS (Larifan) ietekme uz melanomas augšanu peļu audzēju modeļos

2020

Melanoma ir ļaundabīgs audzējs, kas veidojas galvenokārt ādā no tur esošajiem melanocītiem. Melanomai ir raksturīga strauja slimības gaita un agrīna metastazēšanās. Tā ir rezistenta pret standarta terapeitiskajām metodēm. Ievērojamais nesenais progress melanomas ārstēšanā arī nav devis gaidītos rezultātus, tāpēc joprojām tiek meklēti jauni melanomas ārstēšanas paņēmieni. Larifan ir bakteriofāga izcelsmes dsRNS (bf-dsRNS), kas iegūta biotehnoloģiskā ceļā no ar bakteriofāgu inficētām E.Coli šūnām. Tai piemīt spējas inducēt interforus (IFN), un tā tiek veiksmīgi pielietota kā pretvīrusu līdzeklis ar retām blakusparādībām. Larifan piemīt arī pret- audzēju aktivitāte. Maģistra darba mērķis bija …

melanomaLarifanBioloģijadsRNSaudzējsmetastāzes
researchProduct